Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm

Pawlyn, C. orcid.org/0000-0002-7190-0028, Schjesvold, F.H. orcid.org/0000-0003-1096-0569, Cairns, D.A. orcid.org/0000-0002-2338-0179 et al. (13 more authors) (2024) Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood Cancer Journal, 14. 134.

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s) 2024. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY-NC-ND 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

Dates:
  • Published: 12 August 2024
  • Accepted: 23 July 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Funding Information:
Funder
Grant number
Cancer Research UK Supplier No: 138573
CTUQQR-Dec22/100002
Depositing User: Symplectic Publications
Date Deposited: 14 Aug 2024 14:14
Last Modified: 14 Aug 2024 14:14
Status: Published
Publisher: Springer Nature
Identification Number: 10.1038/s41408-024-01109-4
Open Archives Initiative ID (OAI ID):

Export

Statistics